May 16 (Reuters) - Valeant Pharmaceuticals International Inc
said on Monday it would raise the discounts to
hospitals on its heart drugs Nitropress and Isuprel to as much
as 40 percent off list prices after shareholder William Ackman
pledged to revisit controversial price increases on the
treatments.
Read more
No comments:
Post a Comment